Current IDD Situation
Salt Situation Analisys
USI Program
Other Interventions
Key Lessons Learnt
Challenges
Future Plans
 
UZBEKISTAN
 
Coutry Profiles> Uzbekistan

Current Iodine Deficiency Disorder Situation

Population

Population: 25.6 million
Population growth rate: 1.62%
Population < 15 years: 35.2%
Birth rate: 26.1 per 1000
Life expectancy at birth: 63.9 years
Infant mortality: 71.7 per 1000

Prevalence of Goiter/ UIE

Median urinary iodine: < 100 mcg/L. A national survey in 1998 reported a goiter prevalence of 40-59%. Urinary iodine levels showed all samples below 100 mcg/L.

A 1988-90 survey showed a mean urinary iodine excretion of 35 mcg/24 hours in Tashkent .

Iodized salt Coverage

Household iodized salt use: 19%


Salt Situation Analysis

Production

Current data on production of salt and iodized salt are uncertain.

Before 1991, all edible salt came from Ukraine and Kazakhstan and contained, by regulations, 25 ppm of KI.

Country has considerable reserves of rock salt. Four production sites were cited in 1997. Some salt is imported from Kazakhstan and other countries. Current packaging needs improvement.

Consumption

Nineteen percent household consumption of iodized salt (MICS, 2000).

Iodine Procurement and Utilization

Before 1991, all edible salt came from Ukraine and Kazakhstan and contained, by regulations, 25 ppm of KI. Salt iodized with KIO3, probably at 25 ppm.

 

Universal Salt Iodization Program

Information, Education, Communication (IEC) Activities

The Institute of Nutrition coordinates the iodine deficiency control program. It has worked with salt producers to promote USI. The Institute also is active in disseminating information to various sectors and the public at large.

Legislation

Legislation requiring USI currently pending.

Program Monitoring and Evaluation

No established IDD control program. Ministry of Health is responsible. Iodized salt is monitored at production and retail levels, but not on a regular basis. Urinary iodine laboratories available.

Impact data need updating, and program needs more vigorous implementation.

 

Other Interventions

1 mg of iodine per day is given to subjects in endemic area as prophylaxis.

Key Lessons Learned

 

Challenges and Constraints

 

Future Plans for Sustained IDD Elimination

 

 

Sources:

IDD NL 18(3):33, 2002

IDD NL 8(1):9, 1992

IDD NL 13(1):4, 1997
 
   

 

  Network for Sustained Elimination of Iodine Deficiency
180 Elgin Street, Suite 1000, Ottawa, ON Canada K2P 2K3 Telephone: +1 (613) 782- 6812 Fax: +1 (613) 782-6838 E-mail: info@iodinenetwork.net